Original cell type does not affect iPS cell differentiation to blood

The effectiveness of reprogramming cells into blood cells is thought to depend on the original cell type and reprogramming method. Researchers show this assumption is actually the result of epigenetic effects, suggesting any founder cell and reprogramming method is feasible for blood production.